المؤلفون: Liming Bao, Hu Dou, Lin Zou, Ling Lu, Xi Chen, Xingjuan Wang, Jie Yu, Yi Huang, Yongchun Su, Junqing Bin

المصدر: Leukemia & Lymphoma. 59:829-836

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, China, Cancer Research, medicine.medical_specialty, DNA Mutational Analysis, Core binding factor, 03 medical and health sciences, Exon, 0302 clinical medicine, Risk Factors, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, medicine, Overall survival, Humans, Clinical significance, Risk factor, Child, Core binding factor acute myeloid leukemia, business.industry, Core Binding Factors, Myeloid leukemia, Exons, Hematology, Prognosis, Survival Analysis, Progression-Free Survival, Leukemia, Myeloid, Acute, Proto-Oncogene Proteins c-kit, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, Immunology, Cohort, Female, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::293a03d36187b87a97af451dc3eb66c8
https://doi.org/10.1080/10428194.2017.1361025